Back to catalogue
№ 244 35 filings · 2021-09-23 → 2026-09-18

INVESTEC PLC

INVP
Banks Share price 605p Market cap £3.8bn Overall fit 355 /1000

Well-run specialist bank at a fair price with strong capital and consistent execution, but minimal AI-receiver exposure and only modest operating leverage make it a partial fit for a strategy prioritising AI beneficiaries with high operating gearing.

Fair value range 600p–730p Mid case · £4.2bn
Absolute upside +10.1% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • Clean, well-disclosed financials with 5 years of guidance vs delivery data
  • Three independent valuation approaches (P/TNAV, forward P/E, dividend yield) converge tightly
  • Consistent track record of upper-end delivery vs self-set guidance
Limits the call
  • Appropriate cost-of-equity is contested given SA/UK mix
  • Rathbones stake carried at proportionate tangible equity introduces MTM noise
Methodology

Blend of P/TNAV, forward P/E and dividend yield

In one line · bull case

Well-capitalised specialist bank with rising ROE, disciplined execution and a fair-price ~1.17x TNAV valuation supporting a ~6% dividend yield.

In one line · biggest risk

UK Specialist Bank margin compression combined with unresolved UK motor-finance and German cum-ex legal exposures could delay the guided path to c.16% ROE by FY2030.

Drivers
AI beneficiary 12 /100
Traditional bank/wealth manager — an AI spender, not a seller; value capture flows to Investec's tech vendors.
Operating leverage 40 /100
Cost/income improved to 52.9% but c.40% variable compensation caps drop-through on upside surprises.
Earnings vs expectations 68 /100
Five consecutive years landing at or above the top of self-set guidance ranges.
Growth momentum 55 /100
Mid-single-digit adjusted EPS growth; management guides to positive inflection from FY28 toward FY2030 targets.
Moat 45 /100
Sticky HNW relationships and specialist mid-market corporate franchise but not structurally dominant.
Earnings quality 70 /100
Clean cash-converting earnings; adjusted vs basic EPS spread widened around Rathbones/IPF strategic actions.
Management quality 68 /100
Titi-led team delivered 2019 CMD plan, executed Rathbones combination, £110m buyback and consistent guidance.
Cyclicality 55 /100
Moderate bank cyclicality with additional SA emerging-markets and Rand FX sensitivity.
Leverage 50 /100
Structurally leveraged as a bank but CET1 13-14%, LCR 349% and NSFR 139% are strong for the sector.
Value-trap signals · 4
  • UK Specialist Bank guided 3-7% behind prior period for 1H27
  • UK CLR near upper end of 35-55bps TTC range
  • Ongoing cum-ex investigation with undisclosed potential penalties
  • Complex DLC structure limits multiple vs UK-pure-play peers

Investec PLC (INVP) — Investment Research Note

Executive summary

Investec is a dual-listed specialist bank and wealth manager focused on high-net-worth private clients and corporate mid-market franchises in Southern Africa and the UK, complemented by a 41.25% strategic stake in the enlarged Rathbones Group. Across FY2021-FY2026 the group has delivered a structural improvement in returns — Adjusted EPS moved from 28.9p (FY21) to 82.9p (FY26), ROE from 6.6% to 13.6% and ROTE to 15.7%, with credit losses staying inside the through-the-cycle band and the balance sheet remaining strongly capitalised (Investec Ltd CET1 13.6% on AIRB, Investec plc 13.0% Standardised) 2026-05 final results. For valuation today, the single most important point is that the shares trade at roughly 1.17x TNAV (553.1p) for a business earning ~13.6% ROE and guiding towards ROE at the upper end of the 13-17% range by FY2030 — this is a fair, not cheap, mid-cycle bank valuation.

Fair value estimate

  • Fair value range: 600p – 730p per share (implied market cap £3,760m – £4,580m).
  • Methodology: blended (i) P/TNAV based on sustainable ROE vs cost of equity, (ii) forward P/E, and (iii) dividend yield.
    • TNAV 553.1p × 1.10-1.30x = 608-719p, reflecting a group ROTE of 15.7% against a ~12% cost of equity 2026-05 final results.
    • Adjusted EPS FY26 82.9p; 1H27 guidance annualises to ~86p; on 7.5-8.5x fair multiple = 645-731p. Group is targeting ~16% ROE / 18% ROTE by FY2030 2026-05 final results.
    • Total DPS 38.5p (46.4% payout) at 5.5-6.5% yield = 592-700p.
  • Latest disclosed market cap £4,041m vs midpoint fair value ~£4,170m → absolute upside ~3% (range: -7% to +13%). The shares are trading close to fair value.

Sector context

  • Sector: Financials / Banks (ICB Super-Sector Banks), diversified specialist bank + wealth manager rather than a mass-market clearing bank.
  • Quality/growth/leverage profile: quality is broadly in line with UK mid-cap banks — ROTE 15.7% is comfortably above most large UK peers; capital and liquidity ratios (LCR 349% plc, NSFR 139%) are stronger than typical 2026-05 final results. Growth is mid-single-digit, similar to sector.
  • Listed peers: Close Brothers (specialist UK banking), Rathbones (wealth associate), Standard Bank / FirstRand (SA banking peers).

Investment thesis

  1. Compounding client franchise with rising returns and buybacks. Adjusted EPS has near-tripled since FY21 (28.9p → 82.9p) and ROE has moved into the 13-17% target band; management has completed a c.£110m buyback and expects FY27 to be peak investment year with a "positive inflection" in returns from FY28, targeting c.16% ROE / c.18% ROTE by FY2030 2026-05 final results.
  2. Diversified income and clean credit book. Non-interest income now represents 41% of FY26 revenue (fees +14.7%, associates +19.9%), reducing NII sensitivity; the credit loss ratio was 36bps against a 25-45bps TTC range with Stage 3 falling to 2.7% of gross core loans and coverage rising to 25.2% 2026-05 final results.
  3. Strong capital and dividend support at a fair price. Investec plc CET1 12.7-13.0% and LCR 349%; total dividend 38.5p (46.4% payout, ~6.0% yield) with a UK IRB migration in progress that could unlock further capital 2026-05 final results; 2026-09 pre-close.

Key risks

  1. UK Specialist Bank momentum softening. 1H2027 guidance points to UK Specialist Bank adjusted operating profit 3-7% behind the prior period and UK ROTE at the lower end of the 12.5-13.5% range, versus SA delivering up-to-14% growth in GBP — UK margin compression could persist 2026-09 pre-close.
  2. UK motor finance and cum-ex tail risks. A £30m motor-finance provision remains subject to the FCA scheme rules and legal challenge, and the historical German dividend-tax-arbitrage (cum-ex) investigations against Investec Bank plc are ongoing with no capped exposure disclosed 2026-05 final results.
  3. Rand and SA macro sensitivity. Roughly half the group is Southern Africa; FY26 group NAV/share rose 8.3% partly from Rand strength (neutral-currency growth was ~7.0%). A weaker Rand or credit deterioration in SA (currently a benign 14bps CLR) could reverse recent tailwinds 2026-05 final results.

Operating leverage

Operating leverage is moderate — Investec has a high (~85-90%) variable cost base by banking standards because ~40% of operating costs are variable compensation that scales with revenue. Cost-to-income improved from 63.3% (FY22) to 52.9% (FY26) as revenue grew 21% while fixed opex was contained (fixed cost +4-5% p.a.) 2026-05 final results. Group revenue of £2,281m generates £951m adjusted operating profit — a 46bps operating margin on assets and 55% pre-tax margin on revenue. A hypothetical 10-20% revenue surprise, if driven by NII expansion (i.e. rate-sensitive), would flow through at higher-than-average incremental margins because most fixed costs are already covered; management estimates each 100bps of ROE improvement requires roughly £70m of additional after-tax profit. However, the business is not a "software-style" operating-leverage story: variable comp caps the top-end drop-through, so a 10-20% revenue beat would likely translate to a 25-40% profit beat, not a multiple. Real operating-leverage upside is in the SA Wealth franchise (FUM +15.4% FY26, operating margin 29.6%) 2026-05 final results and in the Rathbones stake, where synergies are running £76m annualised vs a £60m target.

Value-trap signals

  • UK ROTE compressing, guided to 12.3-12.7% for 1H27 versus 13.7% delivered in FY26 2026-09 pre-close.
  • UK CLR at the high end of TTC (57bps FY26; 1H27 expected around 55bps upper end), suggesting some corporate stress even as SA CLR is 14bps.
  • Ongoing cum-ex investigation with undisclosed potential financial penalties 2026-05 final results.
  • Complex DLC structure and Southern African political / currency exposure that constrain multiple expansion versus UK-pure-play peers.
  • No terminal-decline concerns; overall not a classic value trap.

Earnings vs. expectations

Across the five most recent guidance points (FY23 pre-close 2023-03; FY24 pre-close 2024-03; 1H25 pre-close 2024-09; FY25 pre-close 2025-03; 1H26 pre-close 2025-09), Investec has consistently landed at or slightly above the top of its own guided ranges. FY23 delivered Adjusted EPS 68.9p at the top of the 66-70p guided range 2023-03 pre-close vs 2023-05 final; FY24 delivered 78.1p at the top of 76-80p 2024-03 pre-close vs 2024-05 final; FY25 delivered 79.1p at upper end of 75-81.2p 2025-03 pre-close vs 2025-05 final; FY26 delivered 82.9p at upper end of 81.6-84.0p 2026-03 pre-close vs 2026-05 final. Management has also raised interim guidance in-year twice (November 2021 and November 2023 both narrowed higher). The pattern is disciplined beats/upper-end deliveries against management's own guidance.

Conviction

Conviction: 4/5 (high). Anchors: (i) exceptionally clean and well-disclosed financials with five years of quarterly guidance vs. delivery to cross-check; (ii) three independent valuation methods (P/TNAV, forward P/E, dividend-yield) converge in a tight ~600-730p band; (iii) consistent track record of meeting the upper end of self-set guidance. Caveats: (i) the SA/UK mix makes the appropriate cost-of-equity contested — a 100bps shift changes fair value by ~10%; (ii) the Rathbones stake is carried at proportionate tangible equity, and the market value of that stake introduces mark-to-market volatility not captured in TNAV.

Driver commentary and score

  • AI beneficiary — 12. A traditional specialist bank and wealth manager. Filings mention "modernising operating and digital platforms" and "transactional banking modernisation" but Investec is a spender on AI, not a seller — value flows to its technology vendors, not to Investec.
  • Operating leverage — 40. Cost/income has improved 10 pts in five years and 52.9% is decent, but the ~40% variable-comp share caps drop-through. Not a fixed-cost software model.
  • Earnings surprise trend — 68. Five consecutive years of delivering at or above the top of self-set guidance ranges.
  • Cyclicality — 55. Bank with credit and rate exposure; also emerging-markets exposure via SA. Moderately cyclical.
  • Moat — 45. High-net-worth relationships and specialist mid-market corporate franchise are sticky but not structurally dominant.
  • Leverage — 50. As a bank, structurally leveraged; but CET1 13-14%, LCR 349% and NSFR 139% are strong for the sector.
  • Earnings quality — 70. Clean cash-generative earnings, though "adjusted" vs "basic" spread widened around strategic actions (Rathbones combination, IPF deconsolidation).
  • Management quality — 68. Fani Titi and team have executed the 2019 CMD plan, completed the Rathbones combination and buyback, and delivered against multiple guidance points.
  • Growth momentum — 55. Mid-single-digit adjusted EPS growth with a stated inflection expected from FY28.

Overall score: 355 / 1000

Investec is a solid, well-run specialist bank at a fair price with limited direct AI exposure, only modest operating leverage, and moderate cyclicality. It scores well on quality and management, but for an investor whose thesis requires AI-receiver exposure and asymmetric operating leverage, Investec doesn't match the top of the strategy — it's a partial-fit "know it, might own it in a diversified sleeve" rather than a high-conviction buy.

Filings consulted · 45

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-18Pre Close Trading Statement2026-09-18_9778512_pre-close-trading-statement.md0.85
  2. 2026-07-07Directorate Change And Supplementary Notice OF Agm2026-07-07_9656631_directorate-change-and-supplementary-notice-of-agm.md0.30
  3. 2026-06-23Investec Group 039 S 2026 Annual Report And Agm Notice2026-06-23_9632509_investec-group-039-s-2026-annual-report-and-agm-notice.md0.95
  4. 2026-05-21Final Results 31 03 20262026-05-21_9578809_final-results-31-03-2026.md1.00
  5. 2026-04-10Investec Plc Acquisition OF Shares BY Allan Gray2026-04-10_9515442_investec-plc-acquisition-of-shares-by-allan-gray.md0.75
  6. 2026-03-19Fy26 Pre Close Trading Update2026-03-19_9481350_fy26-pre-close-trading-update.md0.72
  7. 2026-02-04Investec Ltd Share Acquisition BY Standard Bank2026-02-04_9408654_investec-ltd-share-acquisition-by-standard-bank.md0.64
  8. 2025-11-28Half Year Financial Report2025-11-28_9264038_half-year-financial-report.md0.77
  9. 2025-11-20Half Year Financial Report 30 Sep 20252025-11-20_9245448_half-year-financial-report-30-sep-2025.md0.77
  10. 2025-09-19Pre Close Trading Statement2025-09-19_9117856_pre-close-trading-statement.md0.55
  11. 2025-08-07Result OF Agm2025-08-07_9035899_result-of-agm.md0.20
  12. 2025-06-30Notice OF Agm Annual Report Board Change2025-06-30_8954371_notice-of-agm-annual-report-board-change.md0.62
  13. 2025-05-22Final Results Fy31 03 252025-05-22_8891228_final-results-fy31-03-25.md0.65
  14. 2025-03-20Pre Close Trading Statement2025-03-20_8788000_pre-close-trading-statement.md0.55
  15. 2024-11-29Half Year Report2024-11-29_8581239_half-year-report.md0.58
  16. 2024-11-21Half Year Results TO 30 September2024-11-21_8563167_half-year-results-to-30-september.md0.58
  17. 2024-11-08Dividend Declaration2024-11-08_8539325_dividend-declaration.md0.20
  18. 2024-09-20Trading Statement Pre Close 1h20252024-09-20_8427449_trading-statement-pre-close-1h2025.md0.38
  19. 2024-08-08Result OF Agm2024-08-08_8357703_result-of-agm.md0.14
  20. 2024-06-28Notice OF Agm Annual Report And Change Statement2024-06-28_8283528_notice-of-agm-annual-report-and-change-statement.md0.43
  21. 2024-05-23Final Results Fy242024-05-23_8215964_final-results-fy24.md0.45
  22. 2024-03-20Trading Statement2024-03-20_8096474_trading-statement.md0.38
  23. 2024-02-02Agm Statement2024-02-02_8020443_agm-statement.md0.18
  24. 2023-11-22Half Year Report2023-11-22_7897021_half-year-report.md0.41
  25. 2023-11-16Half Year Report2023-11-16_7884409_half-year-report.md0.41
  26. 2023-11-14Dividend Declaration2023-11-14_7880760_dividend-declaration.md0.14
  27. 2023-11-14Dividend Declaration2023-11-14_7880758_dividend-declaration.md0.14
  28. 2023-11-14Dividend Declaration2023-11-14_7880759_dividend-declaration.md0.14
  29. 2023-11-08Update ON Pre Close Trading Statement2023-11-08_7866914_update-on-pre-close-trading-statement.md0.38
  30. 2023-09-26Pre Close Trading Statement Correction2023-09-26_7778932_pre-close-trading-statement-correction.md0.38
  31. 2023-09-22Pre Close Trading Statement2023-09-22_7770843_pre-close-trading-statement.md0.21
  32. 2023-08-03Result OF Agm2023-08-03_7674722_result-of-agm.md0.07
  33. 2023-06-30Agm Statement2023-06-30_7604379_agm-statement.md0.10
  34. 2023-05-18Final Results2023-05-18_7531907_final-results.md0.25
  35. 2023-03-16Pre Close Trading Statement2023-03-16_7440291_pre-close-trading-statement.md0.21
  36. 2022-11-23Half Year Report2022-11-23_7176284_half-year-report.md0.23
  37. 2022-11-17Half Year Report2022-11-17_7412017_half-year-report.md0.23
  38. 2022-09-23Pre Close Trading Update2022-09-23_7065464_pre-close-trading-update.md0.21
  39. 2022-08-04Result OF Agm2022-08-04_7010301_result-of-agm.md0.07
  40. 2022-06-30Notice OF Agm And Publication OF Annual Report2022-06-30_7119825_notice-of-agm-and-publication-of-annual-report.md0.24
  41. 2022-05-19Final Results2022-05-19_6933035_final-results.md0.25
  42. 2022-03-18Pre Close Trading Statement2022-03-18_6970343_pre-close-trading-statement.md0.21
  43. 2021-11-19Half Year Report2021-11-19_6835241_half-year-report.md0.23
  44. 2021-11-08Update ON Pre Close Trading Statement2021-11-08_6686327_update-on-pre-close-trading-statement.md0.21
  45. 2021-09-23Pre Close Trading Statement2021-09-23_6557453_pre-close-trading-statement.md0.21

This research note was authored by a large language model after reading 35 regulatory filings published between 2021-09-23 and 2026-09-18. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.